Journal ArticleOPEN ACCESS

The Cardiovascular Safety of Diabetes Drugs — Insights from the Rosiglitazone Experience

  • Hiatt W
  • Kaul S
  • Smith R
New England Journal of Medicine (2013) 369(14) 1285-1287
DOI: 10.1056/nejmp1309610
171Citations
Citations of this article
177Readers
Mendeley users who have this article in their library.

Abstract

The management of type 2 diabetes has been challenged by uncertainty about possible cardiovascular effects related to treatment intensity and choice of drug. Although the Food and Drug Copyright © 2013 Massachusetts Medical Society. All rights reserved.

Cite

CITATION STYLE

APA

Hiatt, W. R., Kaul, S., & Smith, R. J. (2013). The Cardiovascular Safety of Diabetes Drugs — Insights from the Rosiglitazone Experience. New England Journal of Medicine, 369(14), 1285–1287. https://doi.org/10.1056/nejmp1309610

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free